Similar Items: Evaluation of novel host markers detected in plasma and saliva as biosignatures for the rapid diagnosis of TB disease and monitoring of the response to TB treatment
- Evaluation of the potential of Mycobacterium tuberculosis antigen-specific host biomarkers detected in QuantiFERON® TB GOLD Plus supernatants in the diagnosis of TB disease
- Characterization of the innate and adaptive immune systems during active TB disease and during treatment
- Immunological markers for active TB and early treatment response indicators
- Evaluation of host biosignatures for targeted screening for tuberculosis at the point of care, and monitoring of the response to TB treatment
- Defining and assessing the spectrum of tuberculosis (TB) disease: application to diagnosis and prognosis
- Investigating host and pathogen biomarkers of mycobacterium bovis and nontuberculous mycobacterial infection in African buffaloes (Syncerus caffer)
Author: Chegou, Novel N.
- Evaluation of the potential of Mycobacterium tuberculosis antigen-specific host biomarkers detected in QuantiFERON® TB GOLD Plus supernatants in the diagnosis of TB disease
- Evaluation of host transcriptional biomarkers in the diagnosis of TB disease and optimization of multi-colour immunophenotyping assay from the QuantiFERON® TB GOLD Plus cell sediments
- Analysis of ex vivo host biomarkers in sputum samples for diagnosis of pulmonary tuberculosis
- Evaluation of host biomarkers for early diagnosis of tuberculosis disease in children
- Chemokine and cytokine measurements using Luminex and Selected Reaction Monitoring (SRM): comparing technologies
- Evaluation of novel host markers detected in plasma and saliva as biosignatures for the rapid diagnosis of TB disease and monitoring of the response to TB treatment